Every SEC Form 3/4/5 on record for this filer (CIK 1353128) — 11 issuers, 43 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | Director | 2020-10-29 → 2026-06-23 | 9 | — |
| HALO | HALOZYME THERAPEUTICS, INC. | Director | 2023-02-06 → 2026-05-07 | 6 | — |
| OVID | Ovid Therapeutics Inc. | Director | 2017-06-15 → 2026-03-02 | 16 | — |
| FUSN | Fusion Pharmaceuticals Inc. | Director · lapsed | 2020-11-03 → 2024-06-04 | 6 | — |
| JNCE | Jounce Therapeutics, Inc. | Director · lapsed | 2017-01-26 → 2023-05-04 | 11 | −$256,220 |
| ADAP | Adaptimmune Therapeutics PLC | Director · lapsed | 2016-06-23 → 2022-07-01 | 7 | — |
| IMMU | IMMUNOMEDICS INC | Director · lapsed | 2019-03-07 → 2020-10-23 | 8 | — |
| GNMX | Aevi Genomic Medicine, Inc. | Director · lapsed | 2017-08-10 → 2020-02-05 | 5 | $75,000 |
| INVA | Innoviva, Inc. | Director · lapsed | 2016-11-21 → 2017-04-24 | 3 | — |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Chief Accounting Officer · lapsed | 2015-07-06 → 2016-10-05 | 8 | −$558,887 |
| MDGN | MEDGENICS, INC. | Director · lapsed | 2015-07-23 → 2016-04-19 | 4 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| JNCE | 2020-09-15 | Sell | 5,000 | $10.50 | $52,500 | — |
4 of 11 issuers are covered and open a security page; the rest are on file here only.
